Hit enter to search or ESC to close
Cortexyme
  • Home
  • Team
  • Pipeline
  • Science
  • News
  • Investors
  • Careers
Cortexyme
Tag

Atuzaginstat

EventsNews

Cortexyme Reports GAIN Trial Data Demonstrated Relationship Between Reduction of P. gingivalis Infection and Slowing of Alzheimer’s Disease Progression

By MacKenzie Lahar | Events, News
News

Cortexyme Announces Partnership with Parkinson Study Group and Upcoming Alzheimer’s Disease Data Presentation

By admin | News
NewsPress Release

Cortexyme Announces Pipeline Update and Anticipated 2021 Milestones

By admin | News, Press Release
EventsPress Release

Cortexyme’s Phase 2/3 GAIN Trial of Atuzaginstat (COR388) in Patients with Alzheimer’s Disease Successfully Advances Past Interim Analysis

By admin | Events, Press Release
Press Release

Cortexyme Announces GAIN Trial of Atuzaginstat in Alzheimer’s Disease Has Exceeded Study Enrollment Target of 570 Patients

By admin | Press Release
NewsPress Release

Cortexyme Announces Issuance of Composition of Matter Patent for Atuzaginstat by the U.S. Patent and Trademark Office

By admin | News, Press Release
News

Cortexyme Announces “Atuzaginstat” Selected as First-in-Class Nonproprietary Name for COR388

By admin | News

Please note our Privacy Policy and Terms of Use. ©2022 Cortexyme

  • Home
  • Team
  • Pipeline
  • Science
  • News
  • Investors
  • Careers